Studies showed that LINC01638 was highly expressed in triple-negative breast cancer (TNBC) tissues and LINC01638 mediated TNBC progression by interacting with c-Myc and activating MTDH-Twist1 signaling [13]. Here, LINC01638 is linked to triple-negative breast carcinoma.